Literature DB >> 20074416

Bronchial anthracofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent.

J Hwang1, L Puttagunta, F Green, A Shimanovsky, J Barrie, R Long.   

Abstract

BACKGROUND: Bronchial anthracofibrosis is a condition of proximal airway narrowing or obliteration and hyperpigmentation in persons with or without a history of occupational dust exposure. It is a bronchoscopic finding that is not uncommonly associated with pulmonary tuberculosis (PTB) in residents of South Korea, Iran and India. It is largely unrecognized in the Western world.
METHODS: We report the frequency of anthracofibrosis in foreign-born PTB patients who underwent bronchoscopy in two cities of Canada. We describe the composition of the pigment in the lungs of patients and speculate on the pathogenesis of anthracofibrosis-associated PTB.
RESULTS: Anthracofibrosis was present in 10/60 (16.7%) foreign-born patients who underwent bronchoscopy and had PTB between 2002 and 2006. Compared to patients from other Asian countries, patients from the Indian subcontinent were more likely to have anthracofibrosis (9/18, 50.0% vs. 1/26, 3.7%, P < 0.001). Carbonaceous particles, silica and silicates predominated in tissue specimens. Proximal airway narrowing appeared to be secondary to mixed dust- and smoke-related anthracofibrosis, PTB, or both.
CONCLUSIONS: Anthracofibrosis is not uncommon in immigrants to Canada from the Indian subcontinent with PTB. PTB may be a responsible or complicating condition in patients with anthracofibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074416

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  16 in total

1.  Bronchial anthracofibrosis with interstitial lung disease: an association yet to be highlighted.

Authors:  Shekhar Kunal; Vikas Pilaniya; Ashok Shah
Journal:  BMJ Case Rep       Date:  2016-01-11

2.  Comparison of samples obtained from bronchoscopy of patients with and without bronchial anthracosis for investigating the prevalence of Mycobacterium tuberculosis.

Authors:  Mohammad Samet; Jamshid Ayatollahi; Atefeh Aboutorabi; Masoud Rahimian; Seyed Hossein Shahcheraghi; Seyed Alireza Mirjalili
Journal:  Germs       Date:  2015-09-01

3.  Image Diagnosis: Bronchial Anthracofibrosis-A Bronchoscopic Diagnosis.

Authors:  Ashok Shah; Shekhar Kunal
Journal:  Perm J       Date:  2017

4.  Bronchial anthracosis: a potent clue for diagnosis of pulmonary tuberculosis.

Authors:  Mostafa Ghanei; Jafar Aslani; Mohammadreza Peyman; Masoud Ahmadzad Asl; Omidreza Pirnazar
Journal:  Oman Med J       Date:  2011-01

5.  Clinical implication of microscopic anthracotic pigment in mediastinal staging of non-small cell lung cancer by endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Young Sik Park; Jinwoo Lee; Jin Chul Pang; Doo Hyun Chung; Sang-Min Lee; Jae-Joon Yim; Seok-Chul Yang; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

6.  Comparison of Clinical and Radiologic Characteristics between Anthracofibrosis and Endobronchial Lung Cancer.

Authors:  Seo Young Yun; Tae Yun Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-05-13

7.  The first described case of occupational anthracofibrosis in the USA.

Authors:  Kamen Rangelov; Sanjay Sethi
Journal:  Case Rep Pulmonol       Date:  2014-12-23

Review 8.  Anthracosis of the lungs: etiology, clinical manifestations and diagnosis: a review.

Authors:  Majid Mirsadraee
Journal:  Tanaffos       Date:  2014

9.  Relationship between bronchial anthracofibrosis and endobronchial tuberculosis.

Authors:  Hyun Ji Kim; Sang Dong Kim; Dong Woo Shin; Soo Hyun Bae; Ah Lim Kim; Ji Na Kim; Seung Wook Jung; Byung Ki Lee; Yeon Jae Kim
Journal:  Korean J Intern Med       Date:  2013-05-01       Impact factor: 2.884

10.  Pattern of pulmonary function test abnormalities in anthracofibrosis of the lungs.

Authors:  Majid Mirsadraee; Amir Asnaashari; Davood Attaran
Journal:  Tanaffos       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.